title: Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
authors.affiliation: Manson Unit, Médecins Sans Frontières (MSF), London, UK catherine.berry@london.msf.org.
authors.forename: Catherine
authors.initials: C
authors.lastname: Berry
authors.affiliation: Research Department of Infection and Population Health, University College London, London, UK.
authors.forename: Tom A
authors.initials: TA
authors.lastname: Yates
authors.affiliation: Manson Unit, Médecins Sans Frontières (MSF), London, UK Department of Paediatrics, Imperial College London, London, UK.
authors.forename: James A
authors.initials: JA
authors.lastname: Seddon
authors.affiliation: MRC Clinical Trials Unit, University College London, London, UK.
authors.forename: Patrick P J
authors.initials: PP
authors.lastname: Phillips
authors.affiliation: Manson Unit, Médecins Sans Frontières (MSF), London, UK.
authors.forename: Philipp
authors.initials: P
authors.lastname: du Cros
mesh_terms: D000995:Antitubercular Agents; D002681:China; D054908:Extensively Drug-Resistant Tuberculosis; D006801:Humans; D000069349:Linezolid; D023303:Oxazolidinones; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant
chemical_list: D000995:Antitubercular Agents; D023303:Oxazolidinones; D000069349:Linezolid